Türkiye, center of pharmaceutical researches

Once Vatan – Pfizer, one of the world’s largest R&D investment making pharmaceutical companies, has signed a Key Strategic Center agreement with Hacettepe University. Having become one of the strategic centers of Pfizer’s global R&D studies, Hacettepe University will now have the opportunity to benefit from Pfizer's 150 year-experience. Melih Memecan, General Manager of Pfizer Türkiye, regarded the agreement as a ‘birth’ and stressed that a crucial step has been taken towards attaching greater importance to pharmaceutical researches in Türkiye.